Healthcare -
Biotechnology - NASDAQ - US
$ 17.06
-3.62 %
$ 1.17 B
Market Cap
-6.16
P/E
ARVN - LONG-TERM DEBT
Long-term Debt ARVN - Arvinas, Inc.
7.3 M
LAST VALUE
40.46%
2 YEAR CAGR
14.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR